CPT1A and lung carcinoma: L-carnitine produced by tumor-associated macrophages (TAMs) activates CPT1A and c-Myc, upregulates NRF2/GPX4 expression, augments antioxidant capacity, and downregulates ACSL4 expression, thereby suppressing ferroptosis in lung cancer cells.